Forward agenda is conversion work: management's own stated priorities are about turning already-secured growth into resu
The model's full reasoning — Q1 2024 call → NO我们根据提供的财报电话会议记录,判断管理层的未来议程是否主要是将已获得的增长转化为交付成果,并且管理层是否传达报告结果尚未显著反映该已获得的增长。 首先,分析管理层的陈述。Jim Clemmer提到:“我们正在继续转型,专注于为全球客户提供价值。”以及“我们相信第一季度展示了我们执行这些期望的能力。”但更具体地,关于未来议程,他提到:“我们期待从这项研究中收集数据,在12个月随访阶段,然后提交数据给FDA,以支持NanoKnife治疗前列腺组织的扩展适应症。”这是关于临床试验和监管提交,属于追求新适应症,不是转化已获得的增长。他还提到:“我们预计在下一个财政季度最终确定研究设计。”关于AngioVac的突破性设备认定,也是关于未来研究。关于AlphaVac,他说:“我们期待很快完成入组,并在30天患者随访期后收集并提交数据给FDA。”这也是临床研究。关于Auryon,他提到:“我们预计在接下来的几个月内获得CE标志。”以及“我们继续做开发规划。”这些都是关于未来批准和开发,不是转化已获得的业务。 关于已获得的增长,他提到:“我们的NanoKnife业务表现非常好,第一季度增长了约36%。”但这是报告的结果,不是未来议程。关于机械血栓切除术,他说:“我们相信我们采取的推动这项业务的措施正在获得积极牵引。”但这是关于改善表现,不是转化已获得的订单。 Steve Trowbridge在财务部分提到:“我们继续预期FY24收入在3.28亿至3.33亿美元之间。”这是指导,不是关于转化已获得的增长。他提到:“我们继续将公司转型,专注于为全球客户提供价值。”但未具体说明未来议程是转化已获得的业务。 在问答环节,Jayson Bedford问及NanoKnife增长,Jim回答:“我们正在看到美国和欧洲的强劲增长。”但这是报告结果。关于AlphaVac,Jim说:“我们喜欢这个产品,医生反馈非常积极。”但未提及已获得的订单或合同。 整体来看,管理层的未来议程主要集中在临床试验、监管提交、产品开发、获得批准等方面,这些属于追求新机会,而不是转化已获得的增长。没有提到已签署的合同、已安装的设备、已招募的患者等需要转化为交付成果。因此,第一部分不成立。 第二部分:管理层是否传达已获得的增长尚未反映在报告结果中?他们提到NanoKnife增长36%,但这是已反映的。关于AlphaVac,他们提到“我们期待完成入组”,但入组是临床研究,不是商业订单。关于Auryon,他们提到“我们预计获得CE标志”,这是未来批准。没有明确说已获得的业务尚未反映在数字中。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| HY | Hyster-Yale Materials Handling, Inc. | Q3 2021 | 2021-11-06 | D |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
EVGO · Q2 2022 → YESThe question is about whether management's forward agenda is about converting already secured growth into results, and if the reported results don't yet reflect that growth. YES The forward agenda centers on converting already-secured growth: the Pilot-GM eXtend deal (up to 2,000 stalls + 500 locations) is described as recently announced and exceeding IRR hurdles, with EVgo procuring, constructing, operating, and maintaining the assets on a capital-light basis; the 2022 guidance is affirmed and tracked, with heavier second-half loads explicitly tied to PFJ and fleet contractual revenues kicking in Q3/Q4 (some already baked into forecasts after late-2021 negotiations); current stall counts (2,397 in operation/under construction, 3,669 pipeline) and throughput explicitly exclude the 2,000-stall Pilot contribution; Delta supply agreement covers the first phase of the PFJ deal through 2026; and execution themes include ramping stalls, commissioning, fleet onboarding, and regulatory credit recognition tied to these committed contracts. The reported Q2 results ($9.1M revenue, 10.
BRBR · Q4 2023 → YESThe question is: On this call, when management describes what the company is focused on over the coming quarters — its own stated priorities, tasks, and to-do list — is that forward agenda substantial...YES The forward agenda centers on converting already-secured growth by ramping production (17% growth in fiscal '23, 20%+ planned for '24 via new co-mans and Michael Foods startup in December), restarting promotions and marketing once supply allows, and scaling the transformed co-man network to fulfill committed demand — all while noting tight supply dynamics persisting through most of fiscal '24. Management explicitly conveys that the reported FY '23 results (22% sales growth, 25% EBITDA growth) reflect only a portion of the secured trajectory, with the bulk of new capacity contributions and promotional lift still ahead in fiscal '24, treating 10-15% sales and 6-15% EBITDA guidance as the meaningful next step rather than a routine continuation.
EFXT · Q3 2023 → YESThe question is: Does management describe their focus over coming quarters as converting already secured growth into delivered results, AND do they convey that reported results don't yet meaningfully ...YES The transcript shows management's forward agenda centers on converting secured growth: executing on the $1.6 billion Engineered Systems backlog for 2024 revenue visibility, realizing remaining USD 60 million synergies from Exterran integration, consolidating facilities, and prioritizing debt reduction plus operational efficiency. They describe this as turning already-committed 2024 activity into delivered results, with the backlog providing "strong visibility into revenue generation and business activity levels for 2024" and embedded margins in line with mid-teens targets.